
Infinimmune
- Infinimmune just raised $75M (Series A) on Aug 11
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
About
Infinimmune is a biotechnology company focused on discovering and developing next-generation antibody therapeutics directly from the human immune system. They leverage their proprietary Anthrobody® platform and GLIMPSE™ antibody language model to identify and optimize fully human antibodies for the treatment of atopic dermatitis, other inflammatory diseases, and cancer.
Show 6 more similar companies
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Shares Biotechnology, Drug Discovery
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Therapeutics
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Genomics
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Artificial Intelligence
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Infinimmune?
People comparing tools land here. Get listed beside these.
Copy Infinimmune's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- infinimmune.com
- Headquarters
- Alameda, United States
- Founded
- 2017
- Founders
- Mike Gibbons, Wyatt McDonnell, Lance Hepler, David Jaffe, Katie Pfeiffer
- Employees
- 22
- Total funding
- $75M (Series A)
- Business model
- B2B
Funding rounds
- $75M11 Aug 2026
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Aug 2026 | Series A | $75M |
Tech stack
Detected on infinimmune.com, last scanned 13 Nov 2026. Run your own scan
- Analytics
- Google Analytics 4
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
Benchmarking
See how your site ranks against 16,849 startups
Infinimmune sits in the 34th percentile for Domain Rating. Check where yours lands, free.
Infinimmune has a Domain Rating of 27, the 34th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Below median
Check yoursEffective DR
Below median
Check yoursAgent Readiness
Above median
Scan yoursSite Speed
Below median
PageSpeedData Trust
Top 25%
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Infinimmune scores 42. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Infinimmune changes
Used Infinimmune? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Is Infinimmune growing?
Yes, fast. Our data shows it raised $75M in a Series A in August 2026.
Who owns Infinimmune?
Infinimmune is privately held. Its founders, including David Jaffe, own part of it. Exact stakes are not public.
Are there companies like Infinimmune?
Yes. We list 6 companies like Infinimmune, including Moderna, BioNTech and Epicrispr Biotechnologies.
What is Infinimmune's Effective Domain Rating?
StartupHub's Effective Domain Rating for Infinimmune is 60 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 20, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Infinimmune trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Infinimmune is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Infinimmune raised?
Infinimmune has raised a total of $75M in funding. The most recent round on record is Series A.
How many employees does Infinimmune have?
Infinimmune has approximately 22 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Infinimmune:
Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Infinimmune and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


